Leukemia research was the focus of a recent Google Hangout hosted by the California Institute for Regenerative Medicine; included in the conversation were Stanford's Ravi Majeti, MD, PhD; Catriona Jamieson, MD, PhD, with the University of California San Diego; and Karen Berry, PhD, DVM, a CIRM science officer. In the words of CIRM blogger Kevin McCormack, "Between the three of them they painted an optimistic look at the state of stem cell research into leukemia, the progress we are making, and the obstacles we still have to overcome."
Majeti, whose works focuses on a potential leukemia treatment using an antibody to a protein called CD47, begins talking around the 10-minute mark.
Previously: Blood cancers shown to arise from mutations that accumulate in stem cells and Leukemia prognosis and cancer stem cells
Related: Cancer roundhouse
